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Control of scrapie, an ovine transmissible spongiform encephalopathy or prion disorder, has been hampered
by the lack of conventional antemortem diagnostic tests. Currently, scrapie is diagnosed by postmortem
examination of the brain and lymphoid tissues for PrPSc, the protein marker for this group of disorders. For
live, asymptomatic sheep, diagnosis using tonsil or third-eyelid lymphoid tissue biopsy and PrPSc assay has
been described. To evaluate the feasibility and efficacy of third-eyelid testing for identification of infected flocks
and individual infected sheep, 690 sheep from 22 flocks were sampled by third-eyelid lymphoid tissue biopsy
and immunohistochemistry. Sheep were further evaluated for relative genetic susceptibility and potential
contact exposure to scrapie. Third-eyelid testing yielded suitable samples for 80% of the sheep tested, with a
mean of 18.1 lymphoid follicles (germinal centers) per histologic section. Three hundred eleven of the sheep
were sampled through passive surveillance programs, in which only sheep with potential contact with an
infected sheep at a lambing event were tested, regardless of their scrapie susceptibility genotype. In addition,
141 genetically susceptible sheep with no record of contact with an infected animal at a lambing event were
sampled through a targeted active surveillance program. Ten PrPSc-positive sheep were identified through the
passive surveillance program, and an additional three PrPSc-positive sheep, including two from flocks with no
history of scrapie, were identified through the active surveillance program. All PrPSc-positive sheep had the
highly susceptible PrP genotype. Third-eyelid testing is a useful adjunct to flock monitoring programs,
slaughter surveillance, and mandatory disease reporting in a comprehensive scrapie eradication and research
program.

and posttranslational structural changes. Regardless of the etiology of scrapie, PrPSc is a reliable marker for infection.
Scrapie transmission is thought to occur by oral exposure to
the causative agent, uptake through the intestinal wall, amplification of the agent in the gut-associated lymphoid and nervous tissue (1, 29), and transport to the brain through the
autonomic fibers of the vagus nerve (11). In U.S. sheep, PrPSc
detected by immunoassay (16, 22) or a transmissible agent
detected by rodent bioassay (9) is found in some lymphoid
tissue by the age of 14 months and in the brain by 2.5 years,
approximately 6 months before onset of clinical signs. Early
accumulation of PrPSc in lymphoid tissue is the basis for preclinical scrapie diagnosis by immunohistochemistry (IHC) assay of postmortem tonsil (28) and antemortem third-eyelid
lymphoid tissue (16) or tonsil biopsy samples (23).
Disease transmission depends on both exposure to the infectious agent and susceptible genetics in the host. Sheep
housed with an infected postparturient ewe (within 60 days of
lambing or abortion) are considered to be at increased risk of
scrapie, presumably because they are exposed to the infectious
agent in placental and fetal tissues or fluids (20, 22, 26, 27).
Following contact with an infected postparturient ewe, disease

Scrapie is a fatal neurologic disease of sheep and goats,
introduced into the United States in 1947 and now endemic in
many states (32). Scrapie is a member of the heterogeneous
group of prion diseases, or transmissible spongiform encephalopathies (TSE), which includes bovine spongiform encephalopathy (BSE), cervid chronic wasting disease, and transmissible mink encephalopathy. Although scrapie is not a zoonotic
disease, the apparent transmission of BSE to humans in the
United Kingdom (4, 31) has resulted in a call for eradication of
all TSE in food-producing animals.
The transmissible agent in scrapie remains controversial because no conventional bacterial, viral, fungal, or toxic source
has been identified. The major component in infectious tissue
homogenates is a relatively denaturation-resistant conformational isoform (PrPSc) of the highly conserved mammalian PrP
protein (PrPC) (13, 21). The prion model proposes that PrPSc
and other less well characterized cofactors induce conversion
of PrPC to the pathogenic isoform PrPSc through aggregation
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TABLE 1. Suitabilitya of eyelid biopsy samples from sheep
of four breeds, aged 1 to 7 years
No. of sheep with at least one suitable
sampleb/no. of sheep tested

Age (yrs)

Hampshire Columbia

1
2
3
4
5
6
7

2/2
1/1
1/1b
2/3
2/4
3/4
0/0

18/18
2/2
7/12
2/3b
1/4
0/0
0/0

b

Suffolk

8/8
6/6b
1/2
4/7b
2/2
4/8
0/1

Total (%) 11/15 (73) 30/39 (77) 25/34 (74)
by breed

Rambouillet

Total (%)
by age
group

0/0
2/2
0/0
0/0
0/0
0/0
0/0

28/28 (100)
11/11 (100)
9/15 (60)
8/13 (62)
5/10 (50)
7/12 (58)
0/1 (0)

2/2 (100)

68/90 (76)

a
Suitable biopsy samples contained more than six lymphoid follicles per section.
b
Both eyes were sampled on nine sheep in the age-breed groups indicated
because the left eye did not appear to have adequate lymphoid tissue when
examined grossly.

occurs almost exclusively in sheep with particular polymorphisms in the host PrP gene (2, 5, 10, 19, 24, 25). In the U.S.
sheep population, scrapie (whether associated with clinical disease or with PrPSc accumulation in the absence of clinical
signs) has been confirmed only in sheep homozygous for the
PrP allele encoding glutamine at codon 171 (QQ171) (17, 18,
30), regardless of breed. In Europe and the United Kingdom,
relative susceptibility of sheep with several other PrP genotypes is reported in various breeds, a finding useful in national
scrapie control programs (6).
Scrapie is typically diagnosed by IHC assay of brain tissue
(12) from sheep with clinical signs of scrapie, notably weight
loss, wool loss, and ataxia. Following diagnosis of an index
animal, control measures in the flock include culling or quarantine of sheep at risk due to susceptible genetics and/or possible contact with the infected postparturient ewe (8). However, many infected sheep die from intercurrent diseases or
routine culling without diagnostic testing, and identification of
infected flocks by surveillance for clinical scrapie alone may
not be sufficient for disease eradication. Cooperative statefederal programs that meet or exceed the current control measures and that are designed to test or improve program procedures or facilitate research are allowed as pilot programs (8).
The state of Wyoming has proposed a pilot program in which
passive surveillance (quarantine, testing, or removal of sheep
having potential contact with an infected ewe) is supplemented
with active surveillance, including live-animal testing of genetically susceptible, clinically normal sheep with no reported
contact with an infected sheep during a lambing event. The
objective of this study was to investigate the feasibility and
efficacy of including third-eyelid testing and susceptibility genetics in active and passive surveillance programs.
MATERIALS AND METHODS
Study flocks. Twenty-two flocks in Wyoming were included in this study.
Ninety sheep from the University of Wyoming Animal Science Department were
sampled by third-eyelid biopsy to estimate the efficiency of eyelid biopsy sampling (percentage of sheep with suitable biopsy samples) for sheep of various
ages and breeds. The sheep were aged 14 months to 7 years and represented four
breeds (Suffolk, Columbia, Hampshire, and Rambouillet) (Table 1). In addition,
600 sheep from privately owned flocks in Wyoming were tested (Table 2). These
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sheep were of Suffolk and Hampshire origin. All sheep over the age of 14 months
at the time of testing were sampled in flocks 1 to 5 and 7 to 13. Only sheep over
the age of 14 months and considered at risk due to potential contact with a
postparturient ewe subsequently diagnosed with scrapie (see “Relative risk designation” below) were sampled in flocks 6 and 14 to 16. The group designated
flock 16 (Table 2) represents one sheep with potential contact risk from each of
five flocks and two sheep with potential contact risk from a sixth flock. Flocks
were included in the study following identification of an infected animal or an
animal with potential contact exposure, either born into the flock (flocks 3 to 5)
or purchased (flocks 6 to 16). Flocks 1 and 2 were volunteered by the producers
for educational purposes or due to industry concerns about scrapie.
Restraint. One eye on each sheep, usually the left eye, was pretreated with
topical 0.5% sterile ophthalmic proparacaine HCl (Bausch and Lomb, Tampa,
Fla.) several minutes before the procedure was performed. The sheep was haltered and restrained manually. All sheep were sampled on the farm of origin, and
equipment for restraint of the sheep varied among the facilities. Many farms
were equipped with a fitting stand, in which the head was immobilized by resting
the chin on a horizontal support and securing a restraint strap behind the head.
Alternative restraint devices included a tilt table in which the sheep was restrained in a squeeze chute, or a head catch in which partial restraint was
afforded by a stanchion. In all cases, immobilization of the head was achieved
through traction on the halter strap. Optimally, one operator restrained the
sheep’s body, one operator maintained control of the halter, one person retracted the third eyelid, and a fourth person collected the biopsy specimen. If
only two operators were available, equipment suitable for restraint of the sheep
was needed; one operator maintained control of the halter and retracted the
third eyelid, and one operator collected the sample.
Biopsy sample collection. After adequate immobilization of the sheep, the
third eyelid was retracted by using 1 by 2 toothed forceps (Econo Thumb Tissue
forceps 21-762; Sklar Instruments, West Chester, Pa.) and treated again with
proparacaine. The lymphoid tissue was visualized on the bulbar surface as a
slightly raised pink tissue on either side of the midline (Fig. 1, lower arrow). The
color, location, and size of the tissue varied slightly among individual sheep.
Sheep were sampled even if there was no gross evidence of lymphoid tissue. The
tissue was grasped with a second set of forceps, raised slightly from the underlying connective tissue, and excised with single-use curved Metzenbaum scissors
(Econo Metzenbaum scissors 21-336; Sklar Instruments) by using a medial to
lateral cut; typically, two or three sequential cuts with the scissors were required
to acquire a single biopsy specimen of sufficient size containing the entire area of

TABLE 2. Flocks and sheep sampled by third-eyelid biopsy
and PrP genotyping
Flock
no.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Total

a

No. of sheep sampled per
surveillance programa
(no. of PrPSc-positive sheep)
Active

Passive

Neither

33 (1)
12 (1)
0
0
0
0
17
15
27
31 (1)
0
1
4
1
0
0
141

0
0
32 (1)
117
115 (6)
8 (1)
0
2
6
2 (1)
6 (1)
4
4
1
7
7
311

19
39
0
0
0
0
11
15
28
47
2
1
8
0
0
0
148

% of sheep with
suitable biopsy samples
(mean follicle count per section)

83 (9.5)
72 (34.4)
81 (26)
73 (15.7)
74 (11.1)
75 (11.5)
78.5 (13.5)
74 (13.6)
68 (14.9)
87 (32.9)
87 (28.3)
50 (6.7)
75 (15.3)
100 (15)
57 (15.5)
86 (13.7)
80 (18.1)

Passive surveillance includes all sheep with potential contact risk, as defined
in Materials and Methods, regardless of genotype. Active surveillance includes
only genetically susceptible sheep with no reported contact risk. Sheep with
neither potential contact risk nor high genetic susceptibility were sampled in
some flocks.
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FIG. 1. Bulbar surface, nictitating membrane of a Suffolk sheep.
The lymphoid tissue is typically visualized as a slightly raised, red to
pink area (lower arrow). Complete excision of the lymphoid tissue
(upper arrow) is visible approximately 2 months after biopsy. The
lymphoid tissue at this site does not regenerate.

lymphoid tissue on one side of the midline (Fig. 1, upper arrow). The biopsy
sample was fixed in 10% neutral buffered formalin for at least 24 h.
Tissue processing. Typically, fixed biopsy samples were observed to be folded
in half with the lymphoid tissue facing outward, secured by the indentation
formed by the forceps teeth. Biopsy samples were opened using iris scissors and
placed flat between biopsy sponges in plastic histopathology cassettes. The lymphoid tissue was placed down in the cassettes. Cassettes with properly positioned
biopsy samples were immersed in 95 to 98% formic acid for 1 h to decontaminate
the tissue (3). Samples were rinsed in three changes of deionized water and for
at least 10 min in running deionized water, then reequilibrated in 10% neutral
buffered formalin. Tissues were processed conventionally and embedded in paraffin; care was taken to position the biopsy samples in the paraffin blocks so that
the lymphoid tissue was facing and on the same plane as the surface of the block,
to provide the largest possible section when cut.
Adhesion of formic acid-decontaminated tissue to glass slides required additional attention during preparation. Three- to five-micrometer-thick sections
were cut with a microtome and applied to adhesive-coated aminosilane-treated
slides (Newcomer Supply, Middleton, Wis.). Residual moisture under the section
was removed with absorbent laboratory tissue paper, and slides were positioned
vertically to dry for at least 1 h. Slides were baked at 57°C for approximately 15 h
(overnight) to remove excess paraffin.
Immunostaining. Sections were rehydrated through xylene substitutes and
graded alcohols, then treated with 95% formic acid (7) for 5 min and neutralized by three changes of 0.1 M Tris-HCl, pH 7.6. Antigen retrieval was
performed by incubation at 120°C in a medical pressure cooker (BioCare
Medical, Walnut Creek, Calif.) for 20 min in a modified citrate buffer (Target
Retrieval solution, pH 6.1; Dako Corporation, Carpinteria, Calif.). IHC was
performed on an automated immunostainer (NexES; Ventana Medical Systems, Tucson, Ariz.) by using the manufacturer’s detection reagents (antibody
diluent, AEC detection kit, hematoxylin, bluing, and mouse immunoglobulin
G1 [IgG1] negative control antibody). The primary antibody was a cocktail of
two monoclonal antibodies (MAbs) to separate epitopes on the PrP molecule
(MAb F99/97.6.1 [14] and MAb F89/160.1.5 [15]; Veterinary Medical Research Development, Inc., Pullman, Wash.) at 5 g/ml each in antibody
diluent (Ventana Medical Systems) filtered through a 0.22-m-pore-size syringe top filter. The primary antibody was applied for the maximum time
available with the automated system (32 min), followed by biotinylated goat
anti-mouse IgG, streptavidin-conjugated horseradish peroxidase, and 3-amino-9-ethylcarbazole as a chromogen. The default settings for incubation time
and temperature provided by the manufacturer were used for all detection
steps. The slides were counterstained with hematoxylin, rinsed, and covered
with coverslips by use of a compatible mounting medium (Faramount aque-
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ous mounting medium; Dako). Lymphoid tissue (tonsil or retropharyngeal
lymph node) from an infected sheep was used as a positive control. Negative
controls included replacement of the primary anti-PrP antibodies with an
isotype control antibody (Ventana) and assay of tissues from uninfected
sheep. Lymphoid follicles appearing as discrete oval or round areas with a
darker border (Fig. 2) were counted on each section. Sections were considered “PrPSc detected” if a granular red precipitate was noted in lymphoid
follicles (germinal centers) (Fig. 2), regardless of the number of follicles in
the section. Sections were considered “no PrPSc detected” if no precipitate
was noted in a section. A minimum of six lymphoid follicles per section were
needed for this designation. Sections with no immunostaining and fewer than
six lymphoid follicles were scored “insufficient lymphoid tissue for determination.” All IHC assays were scored by trained observers with no knowledge
of the potential contact or genetic susceptibility status of the sheep.
Relative risk designation. Sheep were scored for potential contact risk by
using producer records and the definitions established in the Code of Federal
Regulations 79.4 (8). Briefly, sheep were defined as high risk by potential
contact if they were born in a flock during the same lambing season as a
lambing event by a sheep subsequently diagnosed with scrapie. Lambing
events include the birth of an infected sheep as well as parturition or abortion
by an infected ewe in any year of her life. Sheep were considered to be at
lower risk by contact if they were born on the farm at other times, in different
lambing facilities on the same farm, or on farms without reported cases of
scrapie. If an infected ewe had produced at least one lamb at the facility and
no birth records were available for the flock, all sheep born in the flock during
the years that the infected ewe lambed or aborted were designated high risk.
Relative contact risk status was based on producer records, and no outside
measure of the accuracy of those records is available. No producer could rule
out a previously undetected scrapie case, because some of the clinical signs
(particularly weight loss) occur frequently in these flocks and result in culling
of the animal without diagnostic testing.
Sheep were scored for relative genetic susceptibility based on the deduced
amino acid sequence at residue 171. Blood was collected by jugular venipuncture
into EDTA-treated vacuum tubes and shipped to a commercial laboratory for
scrapie susceptibility testing (GeneCheck, Fort Collins, Colo.). DNA was extracted from the buffy coat, amplified by PCR, and analyzed by a DNA mismatch
binding assay. The diploid genotype was reported as QQ, QR, or RR. However,
this assay does not distinguish between sequences encoding glutamine (Q) and
sequences encoding histidine (H) (both are reported as 171Q), and samples
scored QQ may actually be QQ, QH, or HH. Samples scored QR may be QR or
HR. Samples scored RR are unequivocally homozygous for arginine (R) at
position 171. Sheep were considered to have high genetic susceptibility if their
genotype was 171QQ, 171QH, or 171HH and to have lower genetic susceptibility
if their genotype was 171QR, 171HR, or 171RR.
Surveillance programs. Under the current program, passive surveillance includes testing of all sheep in flocks in which an infected animal was born or
produced a lamb and all sheep sold from those flocks if they were born in a year
in which the infected ewe produced a lamb. The passive surveillance program
therefore includes sheep with potential contact with the transmissible agent shed
at parturition, even if those sheep are at low genetic risk. Active surveillance
includes only genetically susceptible sheep with no reported contact risk. In some
flocks, all sheep over the age of 14 months were sampled, even if they were not
eligible for either program. The number of sheep sampled in each surveillance
program (or sampled as whole-flock testing but enrolled in neither program) is
shown in Table 2.

RESULTS
Third-eyelid biopsy samples were collected from a university-owned flock to determine if particular breeds of sheep or
age groups were unsuitable for this procedure. Ninety sheep of
four breeds were available for sampling (Table 1). Suitable
samples were those with at least six lymphoid follicles per
section. Nine sheep were sampled twice because the left eye
did not appear to have adequate lymphoid tissue when examined grossly. Five of these nine animals had suitable biopsy
specimens from both eyes. One animal, a 5-year-old Columbia,
had unsuitable samples from both eyelids. Three animals had
one suitable sample and one unsuitable sample; this group
included a 3-year-old Hampshire, a 4-year-old Columbia, and
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FIG. 2. IHC detection of PrPSc in the nictitating membrane lymphoid tissue. A third-eyelid biopsy specimen from a live sheep with preclinical
scrapie is shown. Lymphoid follicles (discrete round to oval accumulations of lymphocytes, macrophages, and dendritic cells with a dark border)
show granular PrPSc immunoreactivity (red) when immunostained with a cocktail of MAbs F89/160.1. and F99/97.6.1. Bar, 200 m.

a 2-year-old Suffolk. The overall efficiency of testing was 76%
(68 of 90) when the results from either eyelid were used to
score an individual sheep. There was no breed for which all
samples were unsuitable. There was a trend toward a lower
percentage of suitable samples from sheep older than 3 years,
but a larger study population is needed before conclusions on
the feasibility of testing older sheep can be drawn.
A total of 600 sheep from 21 producer-owned flocks (Table
2) were assessed for evidence of infection with the scrapie
agent by IHC of third-eyelid biopsy samples and for relative
genetic susceptibility to scrapie by DNA genotyping. Sampled
sheep were over the age of 14 months and were primarily of the
Suffolk or Hampshire breed. Sheep were housed in flocks with
no reported cases of scrapie, flocks in which an infected ewe
was born or had produced at least one lamb, and flocks with at
least one purchased animal with potential contact exposure in
the flock of origin (Table 3). The PrP genotypic ratio in this
sample was 0.48:0.52 (290 sheep with the highly susceptible
171QQ, -QH, or -HH genotype and 310 sheep with the lowersusceptibility 171QR, -RH, or -RR genotype). This ratio is not
significantly different from that reported for an independent
sample of 1,000 U.S. Suffolk sheep in 1996 (18).

Three hundred eleven of the 600 sheep in the study were
tested under passive surveillance programs (Table 2), representing sheep with potential contact risk from exposure to an
infected ewe at parturition. Eighty-five of 311 had the highly
susceptible genotype. One hundred forty-one of the 600 sheep
were tested under the Wyoming active surveillance program

TABLE 3. Flock status at the time of testing and risk status
of PrPSc-positivea sheep
No. of PrPSc-positive sheep
Flocks

1 and 2
3–5
6–16
Total
a

Pretest flock
statusb

None
Birth
Purchase

Total

2
7
4
13

With potential
contact risk

With genetic
susceptibility

High

Lower

High

Lower

0
1
3
4

2
6
1
9

2
7
4
13

0
0
0
0

Sheep with PrPSc detected in lymphoid follicles of the third eyelid.
None, no reports of scrapie in the flock; Birth, lambing event by an infected
sheep on the premises; Purchase, the only sheep with reported potential contact
were purchased from other flocks.
b
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and represent genetically susceptible sheep with no record of
contact with an infected sheep at a lambing event, whether
they resided in flocks with a purchased animal with potential
contact risk at a different facility (n ⫽ 96) or in flocks with no
history of scrapie contact in either native or purchased animals
(n ⫽ 45). One hundred forty-eight sheep in the lower-geneticsusceptibility group and with no reported contact with an infected postparturient ewe were tested because they were
housed with sheep in the active surveillance trial.
Sheep were tested for PrPSc, a marker for scrapie, by
third-eyelid lymphoid tissue biopsy and IHC analysis (14).
Biopsy samples of the third eyelid from 481 (80%) of the
sheep tested contained at least six lymphoid follicles (Table
2) and were considered suitable for diagnosis, although all biopsy samples were analyzed by IHC. The mean follicle count in
suitable biopsy samples was 18.1 (standard deviation, 13.3).
PrPSc was detected in 13 of the biopsy samples, collected
from sheep on seven farms (Table 3). All 13 sheep with PrPSc
detected in lymphoid tissue had the highly susceptible PrP 171
genotype QQ, QH, or HH. Of the 13 sheep with positive eyelid
biopsy samples, 4 were removed for immediate necropsy, and
scrapie was confirmed by IHC of brain and/or lymphoid tissues. Nine sheep were moved to quarantine. Scrapie has been
confirmed in seven of these nine sheep by postmortem analysis
following development of clinical signs and in one of these nine
sheep following acute loss (found dead with no clinical signs).
The last of the nine sheep brought to quarantine is asymptomatic at the age of approximately 36 months.
Ten of the 13 PrPSc-positive sheep were identified by the
passive surveillance program, and 3 were identified by the
active surveillance program. The positive samples were collected from sheep in flocks in which an infected sheep had
been born (n ⫽ 7), flocks with no reported cases of scrapie
(n ⫽ 2), and flocks with at least one sheep purchased from
an infected flock (n ⫽ 4), although in one case, the PrPScpositive sheep was not the purchased sheep with contact risk
but an unrelated animal purchased from a different flock.
The efficiency of the surveillance programs was estimated as
the number of PrPSc-positive sheep per number of sheep in
each program (10 of 311, or 3.2%, in the passive surveillance
program and 3 of 141, or 2.1%, in the active surveillance
program).
DISCUSSION
Scrapie was reported as a clinical entity nearly 300 years ago
and was introduced into the United States in 1947. In the
United States, control programs have relied on total or partial
flock depopulation following diagnosis of the disease in a
sheep with clinical signs of scrapie. The insidious nature of the
disease, the long preclinical incubation period, the lack of a
preclinical test, loss of infected sheep from intercurrent disease
before development of clinical signs, and underreporting of
scrapie due to the negative economic effect of a diagnosis have
contributed to the failure of these programs to control the
prevalence of scrapie, which is estimated at 0.07% in the
United States (based on a mailed producer survey conducted
in 1996 by the National Animal Health Monitoring System of
the U.S. Department of Agriculture (USDA) Animal and
Plant Health Inspection Service). State and federal flock cer-
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tification programs, in which producers of monitored flocks
agree to purchase breeding stock from similarly monitored
flocks, permanent identification of individual sheep and/or
flock of origin, and restrictions on interstate movement of
suspect and high-risk animals have been in place since 1992.
The USDA Animal and Plant Health Inspection Service recently expanded the program to include identification of
breeding and mature sheep and breeding goats in interstate
commerce, uniform standards for state scrapie control programs, indemnity payments, slaughter surveillance, and thirdeyelid testing of exposed animals and/or flocks. These programs are being implemented to eradicate scrapie from the
United States.
The development of the third-eyelid test for antemortem
diagnosis of scrapie and the identification of PrP genotypes
associated with clinical and subclinical PrPSc accumulation
have provided additional means for controlling scrapie in the
U.S. sheep population. The estimated specificity of the thirdeyelid test approaches 100% (14). The estimated sensitivity of
the test is 85 to 90%. The false-negative results are due to a
number of factors. Some infected sheep have PrPSc detectable
in the brain but not in lymphoid tissues; in other cases, PrPSc
is detectable in tonsil but not in antemortem eyelid biopsy
specimens, due in part to inadequate biopsy sample size. Optimal sampling conditions include a restraint device such as a
tilt table, fitting stand, or head catch and adequately trained
personnel for immobilization of the head, retraction of the
eyelid, and biopsy sample collection. Laboratory handling of
the tissue to maximize the number of follicles available for
inspection in a single histologic section requires laboratory
personnel trained in recognizing the lymphoid side of the tissue and embedding a flat sample in the plane of the microtome
cut. In other trials, techniques such as embedding strips of
lymphoid tissue at right angles to the plane of the microtome
cut (14) or embedding folded or rolled tissues typically resulted
in small numbers of follicles available for inspection in each
section. In the present study, sampling was performed by one
of three veterinarians (J.V.D., J.R.L., and E.S.W.), and IHC of
samples from producer flocks was performed by one person
(A.K.A.). When sampling, tissue handling, and assay were performed under these circumstances, approximately 80% of the
sheep in each flock could be assessed.
In this study, the third-eyelid test identified PrPSc-positive
sheep in flocks with previous scrapie exposure, although in two
cases the individual sheep identified by eyelid biopsy had no
reported contact with an infected ewe at parturition. The efficiency of the programs (2 to 3% in this relatively small sample) exceeds the estimated scrapie prevalence level of 0.07%
nationally and illustrates the potential value of preclinical surveillance. However, there are some limitations to the use of the
eyelid test in a scrapie eradication program. One hundred to
150 sheep can be sampled per day in a single location with
proficient personnel using restraint equipment available on
most facilities; testing small numbers of sheep at multiple locations decreases the efficiency of the testing personnel. The
costs of personnel, equipment, topical anesthetics, and sample
testing are borne by the state and federal governments through
a joint scrapie eradication program. Although the procedure is
performed under local anesthesia, third-eyelid sampling may
be perceived as objectionable by some producers. The third-
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eyelid test is most useful in animals between the ages of 14 and
36 months, because older animals tend to have smaller areas of
lymphoid tissue. Further, the estimated test sensitivity is approximately 85 to 90%. Therefore, the third-eyelid test is not
suitable as a stand-alone eradication tool. The test is more
appropriately considered an adjunct surveillance tool to identify infected flocks which could then be managed through an
integrated program of testing, necropsy or quarantine, genetic
selection, and husbandry modifications. The test is also useful
for identification of naturally infected sheep for transfer to
research facilities. Although active surveillance is expensive,
cost-effectiveness is increased by targeting the testing program
to 14- to 24-month-old sheep of heavily impacted breeds in
flocks with a history of purchasing breeding ewes from multiple
sources. Active surveillance is a justifiable addition to liveanimal passive surveillance, in which flocks are identified only
after submission of a clinical suspect. One of the sheep quarantined after selection by this program was found dead with no
history of clinical signs, and another remains clinically normal
at the age of 36 months. Inapparently infected sheep such as
these produce lambs annually and serve as a continuing source
of the transmissible agent. Slaughter surveillance and active
live-animal surveillance programs such as the Wyoming pilot
program will be critical for identification of infected flocks and
eventual disease eradication.
This study demonstrated that identification of scrapie-infected flocks by third-eyelid testing is technically feasible with
proficient personnel and adequate field and laboratory resources. Third-eyelid testing and genotype analysis are useful
in identifying infected flocks for regulatory intervention and
infected animals suitable for research purposes. Active surveillance for scrapie is a useful component of an integrated scrapie
control program based on permanent identification, flock monitoring, slaughter surveillance, and passive surveillance by diagnosis of clinical suspects with testing of their scrapie-exposed
flockmates.
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